Literature DB >> 11333931

Feline immunodeficiency virus cell entry.

S C Frey1, E A Hoover, J I Mullins.   

Abstract

The process of feline immunodeficiency virus (FIV) cell entry was examined using assays for virus replication intermediates. FIV subtype B was found to utilize the chemokine receptor CXCR4, but not CCR5, as a cellular receptor. Zidovudine blocked formation of late viral replication products most effectively, including circular DNA genome intermediates. Our findings extend the role of CXCR4 as a primary receptor for CD4-independent cell entry by FIV.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11333931      PMCID： PMC114955          DOI： 10.1128/JVI.75.11.5433-5440.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  32 in total

1.  Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Authors:  R A Olmsted; V M Hirsch; R H Purcell; P R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

3.  Circularization of human immunodeficiency virus type 1 DNA in vitro.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

4.  Diminished human immunodeficiency virus type 1 reverse transcription and nuclear transport in primary macrophages arrested in early G(1) phase of the cell cycle.

Authors:  N A Kootstra; B M Zwart; H Schuitemaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.

Authors:  P R Clapham; D Blanc; R A Weiss
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

6.  Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1.

Authors:  Y Quan; L Rong; C Liang; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes.

Authors:  W C Brown; L Bissey; K S Logan; N C Pedersen; J H Elder; E W Collisson
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

8.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

9.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

10.  Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.

Authors:  C D Pauza; J E Galindo; D D Richman
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307
View more
  12 in total

Review 1.  FIV and neuroAIDS.

Authors:  Howard S Fox; Tom R Phillips
Journal:  J Neurovirol       Date:  2002-06       Impact factor: 2.643

2.  A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.

Authors:  A Bonavia; B T Bullock; K M Gisselman; B J Margulies; J E Clements
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

3.  CD8+ clonality is associated with prolonged acute plasma viremia and altered mRNA cytokine profiles during the course of feline immunodeficiency virus infection.

Authors:  Michelle M Miller; Elizabeth M Thompson; Steven E Suter; Jonathan E Fogle
Journal:  Vet Immunol Immunopathol       Date:  2012-12-20       Impact factor: 2.046

4.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: failure to protect and possible enhancement of challenge infection by four cell-based vaccines prepared with autologous lymphoblasts.

Authors:  Simone Giannecchini; Patrizia Isola; Olimpia Sichi; Donatella Matteucci; Mauro Pistello; Lucia Zaccaro; Daniela Del Mauro; Mauro Bendinelli
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 5.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

6.  Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.

Authors:  Simone Giannecchini; Armida Di Fenza; Anna Maria D'Ursi; Donatella Matteucci; Paolo Rovero; Mauro Bendinelli
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

7.  FIV establishes a latent infection in feline peripheral blood CD4+ T lymphocytes in vivo during the asymptomatic phase of infection.

Authors:  Brian Murphy; Natasha Vapniarsky; Chad Hillman; Diego Castillo; Samantha McDonnel; Peter Moore; Paul A Luciw; Ellen E Sparger
Journal:  Retrovirology       Date:  2012-02-07       Impact factor: 4.602

8.  Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein.

Authors:  María J Esteva; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

9.  Interaction of short modified peptides deriving from glycoprotein gp36 of feline immunodeficiency virus with phospholipid membranes.

Authors:  Gerardino D'Errico; Giuseppe Vitiello; Anna Maria D'Ursi; Derek Marsh
Journal:  Eur Biophys J       Date:  2009-05-05       Impact factor: 1.733

10.  Structural basis of antiviral activity of peptides from MPER of FIV gp36.

Authors:  Manuela Grimaldi; Ilaria Stillitano; Giuseppina Amodio; Angelo Santoro; Michela Buonocore; Ornella Moltedo; Paolo Remondelli; Anna Maria D'Ursi
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.